|
Life sciences 2009 - 2010 events Upcoming events
- 2010 BIO International Convention
May 3-6, 2010
Chicago, IL - BIO National Venture Conference
March 2010
Boston, MA - BIO CEO and Investors Conference
February 8-9, 2010
New York, NY
Past events - BIO-Europe International Partnering Conference
November 2-4, 2009
Vienna, Austria - Eucomed Medtech Forum & General Assembly 2009
October 6-8, 2009
Brussels, Belgium - Advanced Medical Technology Association
October 12-14, 2009
Washington, D.C. - BIO Investor Forum
October 28-29, 2009
San Francisco, CA - BioEquity Europe 2009
June 9-10, 2009
Munich, Germany - International Medical Device Compliance Congress
May 09, 2009
Rome, Italy - BIO International Convention
May 18-21, 2009
Atlanta, GA - Association of Bioscience Finance Officers (ABFO) National Conference
May 26-29, 2009
Philadelphia, PA - BIO National Venture Conference
March 31-April 1, 2009
Boston, MA - BIO CEO and Investors Conference
February 9-10, 2009
New York, NY
La Baule 2009 - 7th World Investment Conference "Making Europe More Attractive and Competitive"
3 - 5, June 2009,
Paris, France
www.labaulewic.org More than 1,000 global business leaders will come together at this premier event to exchange ideas and design concrete proposals for enhancing Europe's attractiveness. This conference will also serve as an ideal marketplace for policymakers and investors seeking opportunities, innovation and partnerships.
Ernst & Young will announce the results from its annual survey highlighting the attractiveness of Europe and its regions. - 15th Annual International Russian Pharmaceutical Forum
19 - 21, May 2009,
Saint-Petersburg, Russia
www.adamsmithconferences.com
Hosted by Adam Smith Conferences, the 15th annual forum is one of the most significant events in the Russian pharmaceutical industry. The 50-plus strong speaker faculty is represented by top executives from leading companies working in the Russian pharmaceutical sector. - International Pharmaceutical Regulatory and Compliance Congress
28 - 29, May 2009,
Rome, Italy
www.InternationalPharmaCongress.com
Ernst & Young is proud to be a lead sponsor of the third annual International Pharmaceutical Regulatory and Compliance Congress. This premier event will bring together leading pharmaceutical regulatory and compliance professionals to network and share insights on significant topics, including compliance in a tough economy, fraud and clinical trials in emerging markets and FCPA issues.
- Windhover: Pharmaceutical Strategic Outlook 2009
13 - 15, April 2009,
New York, New York
www.windhover.com
This annual event, sponsored by Ernst & Young, will examine last year’s most important strategic alliances, look ahead to the coming year and provide insights on maximizing strategic alliance opportunities. Hear discussion on what’s next for the broader biopharma worlds – models that break down the walls between Big Pharma, biotech and specialty pharma pipelines, and open up the financing opportunities to much broader investment audiences. CBI 5th Annual Pharmaceutical and Biotech Accounting and Reporting Congress
16 - 17, March 2009,
Philadelphia, PA
www.cbinet.com As a sponsor of this important annual event, Ernst & Young invites you to hear key leaders and representatives from the industry present insights on current and upcoming accounting and reporting practices specific to life sciences companies. Speakers will cover key topics such as changing regulations, technical accounting, auditing and financial reporting best practices and the specific challenges and requirements of pharmaceutical and biotech companies. Ernst & Young life sciences transfer pricing roundtable
11, March 2009,
Morristown, NJ
Ernst & Young will be hosting the life sciences transfer pricing roundtable, a roundtable series focusing on the international tax challenges related to transfer pricing facing senior-level tax professionals in the life sciences industry. To foster discussion, interaction and open dialogue, participation will be limited to international tax professionals from select multinational life sciences companies.
Questions and RSVP:
Contact Elite Rubin or call 212-773-6792 - Webcast: Is the Obama administration good medicine for the drug, biotech and medtech industries?
20 February 2009
Hear a replay of our webcast with leaders from PhRMA, Biotechnology Industry Organization and AdvaMed on the impact of the new administration on life science industries. - Adam Smith Conference’s 14th Annual Russian pharmaceutical forum
20 - 22 May, St. Petersburg, Russia
Ernst & Young is a sponsor of this forum, which will discuss the Foreign Corrupt Practices Act (FCPA) and pharmaceutical promotional practices. What is the FCPA and what is its scope? How is the pharmaceutical industry implicated in the statute? What are some of the risk areas? What are examples of its applicability? What are some of the preventive and remedial actions? Contact: www.russianpharma.com - International Pharmaceutical Regulatory and Compliance Congress
6-7 June 2007
Brussels, Belgium
www.internationalpharmacongress.comErnst & Young is proud to have sponsored the first annual International Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum. The event brought together global leaders in the pharmaceutical industry to discuss emerging issues, current trends, regulations, and enforcement initiatives. The program was highly interactive and offered several networking opportunities. John Smart and Ted Acosta from Ernst & Young presented, along with top executives from international pharmaceutical companies, regulators from countries around the world, and seasoned legal and compliance professionals. Additionally, the Ernst & Young Global Pharmaceutical Center launched Progressions 2007 at this event. - Annual BIO conference
6-9 May 2007
Boston, US - Risk Advisory roundtable
20 April 2007
Berlin, Germany - Pharma CIO roundtable
29 March 2007
New York, US - Pharma Sector Risk Advisory/Indirect Tax roundtable
15-16 March 2007
Boston, US
|
| |
|
